2nd Gene Therapy Potency Assay Summit 2024
July 16 - 18, 2024 - MA USHanson Wade
info@hansonwade.com
Phone:+1 617 455 4188
The 2nd Gene Therapy Potency Summit is returning to Boston in July to support you in designing and validating robust potency assays to accelerate commercialization across a range of vector types and delivery modalities. Featuring a speaker faculty of over 27 industry-leading experts from key biotech and pharmaceutical companies, this summit offers the most comprehensive agenda to date. From case studies on phase-appropriate assay development to novel data presentations on cutting-edge HPLC and mass-spectrometry-based approaches, this year's program covers unique and diverse challenges that potency poses for complex gene therapies. Uniting 100+ potency assay developers and solution providers from the likes of Sarepta Therapeutics, Ultragenyx, Sanofi, Spark Therapeutics, Vertex, Sangamo Therapeutics, and many others, this is your critical chance to learn from companies working on gene therapies from early development through to commercialized products. Join us in July to engage with critical decision-makers, stay on top of industry trends, and gain key insights on ways to build out a solid potency strategy to ultimately prove to regulators that your product is efficacious. Time: 9:00 AM - 5:30 PM